Case Report: Omalizumab combined with voriconazole for the treatment of ABPA complicating IPA: a case report
Aspergillus invading hosts may manifest as Allergic bronchopulmonary aspergillosis (ABPA) or invasive pulmonary aspergillosis (IPA) in individuals with varying immune statuses. ABPA predominantly occurs in severe asthma patients, whereas IPA is typically observed in immunocompromised individuals. AB...
Saved in:
| Main Authors: | Tingrui Zhao, Yukai Chen, He Sun |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1588182/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Steroid-Sparing Effect of Omalizumab in Stage IV (Corticosteroid Dependent) Allergic Bronchopulmonary Aspergillosis
by: P. C. Kathuria, et al.
Published: (2020-04-01) -
An asthmatic child with allergic bronchopulmonary aspergillosis (ABPA)
by: Öner Özdemir
Published: (2018-08-01) -
Recurrent Pulmonary Infection Caused by Schizophyllum commune: A Case Report and Management of Inflammation
by: Shuai Ren, et al.
Published: (2025-07-01) -
Proposal and Verification of New Revised Criteria for ABPA/ABPM Diagnosis
by: Cai R, et al.
Published: (2025-04-01) -
A multidimensional grading system for ABPA treatment escalation within the first year: The HEID score
by: Zhang Ping'an, MD, et al.
Published: (2024-12-01)